← Search

Data · dataset · 2024

Vogt-Koyanagi-Harada like posterior uveitis during treatment by Anti-programmed Death-1 antibody for lung cancer: 2 case reports and review

Listed in Teesside University Research Data Repository

The use of anti-programmed death (PD)-1 antibodies could induce Vogt-Koyanagi-Harada (VKH) like posterior uveitis.

Description

We present two cases of VKH-like posterior uveitis that developed during anti-PD-1 antibody therapy for lung cancer. In Case 1, the patient presented with severe hyalitis and choroidal thickening.

Multimodal ocular images led to a diagnosis of VKH-like uveitis secondary to anti-PD-1 therapy. Following cessation of anti-PD-1 treatment and oral prednisone, visual acuity improved. In Case 2, the patient experienced bilateral severe blurred vision.

Read the rest (2 more)

The left eye exhibited diffuse serous retinal detachment with choroidal detachment, which responds slowly to corticoid therapy. The right eye demonstrated wavy retinal pigment epithelium initially and then complicated with rhegmatogenous retinal detachment. Both eyes underwent vitrectomy with silicone tamponade.

His visual acuity remained hand motions. This data contains all the original images and photographs of ocular examinations during their treatment.

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Cancer 75% · Image 65%
Provenance · 1 source records, 8 field assertions
SourceKeyLast seenRaw
Teesside University Research Data Repositoryoai:data.mendeley.com/pgrk43chrc.19 h agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[disease].local:disease:cancerenrichment · researchdata tees ac ukkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:earth-environmentalmapping · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[modality].local:modality:imageenrichment · researchdata tees ac ukkeyword-concept-rules@1.0.0title+description (65%)
descriptionsource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/description
licensesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/rights
publication_datesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
titlesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/title